Community Health Worker And MHealth to ImProve Viral Suppression

Persons living with HIV (PLWH) now achieve a near-normal life expectancy due to antiretroviral therapy (ART) which has transformed HIV from a terminal diagnosis to a manageable chronic condition. Despite widespread availability of ART in the United States (US), many of the country's approximate 1.1 million PLWH are not fully benefitting from ART due to poor adherence. These suboptimal HIV health outcomes occur at a time when clinicians have limited time and the US healthcare system remains fragmented, further exacerbating the challenges inherent in the lives of underserved, marginalized groups, such as PLWH. Therefore, the development and evaluation of interventions using a cadre of community health workers (CHW) holds promise for addressing these challenges in the US. This study addresses limitations in current research on CHW interventions to improve viral suppression and ART adherence. The investigators propose to build on strong preliminary data to strengthen a community health worker (CHW) intervention using an existing mHealth approach, and provide further information regarding the successful wide-scale implementation of this combination intervention.

Inclusion criteria

• Be able to communicate and read in English or Spanish
• Willing to participate in any assigned arm of the intervention
• Diagnosed with HIV ≥6 months ago
• Have an HIV-1 RNA level >200 copies/mL, or have at least one "no-show" visit in the past 12 months, or report being virally unsuppressed in the past 12 months
• Have ART adherence <80%, as measured through Single-Item Self-Rating Adherence Scale (SRSI)
• Own a smartphone

Exclusion criteria

• Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment
• Terminal illness with life expectancy <6 months
• Planning to move out of the area in the next 12 months